ND Capital
NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed ND Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
NanoDimension is a leading venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences. We focus on early stage opportunities in the US and Europe led by exceptional entrepreneurs. NanoDimension’s investment team takes an active approach to building portfolio companies, leveraging our expertise and network to find and build companies with innovative solutions to critical global problems.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 2/2016 | ARMO BioSciences | Series C | 50M |
| 6/2012 | View | Series D | 0 |
| 10/2016 | Emulate | Series B | 0 |
| 11/2007 | BIND Therapeutics | Series B | 16M |
| 7/2020 | Natron Energy | Series D | 0 |
| 2/2018 | H55 | Venture Round | - |
| 5/2010 | Crocus Technology | Series C | 0 |
| 1/2016 | Pulse Therapeutics | Venture Round | 10M |
| 7/2013 | Crocus Technology | Series D | 0 |
| 4/2010 | Selecta Biosciences | Series C | 15M |
| 2/2017 | Inscripta | Series B | 23M |
| 1/2012 | Tarveda Therapeutics | Series A | 2.8M |
| 5/2014 | ARMO BioSciences | Series B | 30M |
| 6/2015 | Crocus Technology | Series E | 21M |
| 12/2013 | Tarveda Therapeutics | Series B | 21M |
| 7/2014 | Emulate | Series A | 12M |
| 4/2019 | Inscripta | Series C | 0 |
| 1/2015 | Tarveda Therapeutics | Series B | 21M |
| 1/2016 | Twist Bioscience | Series D | 61M |
| 11/2013 | View | Venture Round | 12.6M |
| 10/2008 | Crocus Technology | Series B | 15.9M |
| 7/2018 | Serotiny | Seed Round | 3M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 9/2015 | Selecta Biosciences | Series E | 38M |
| 6/2010 | BIND Therapeutics | Series C | 12.4M |
| 5/2020 | SQZ Biotech | Series D | 0 |
| 2/2009 | Selecta Biosciences | Series B | 15.1M |
| 10/2014 | Selecta Biosciences | Private Equity Round | 20M |
| 9/2016 | SQZ Biotech | Series B | 16M |
| 4/2021 | Icosavax | Series B | 0 |
| 12/2010 | View | Series C | 40M |
| 2/2017 | Tarveda Therapeutics | Series D | 30M |
| 8/2018 | SQZ Biotech | Series C | 0 |
| 5/2014 | Twist Bioscience | Series B | 26M |
| 12/2018 | Inscripta | Series C | 0 |
| 2/2018 | Inscripta | Series C | 55.5M |
| 12/2019 | Arctos Medical | Seed Round | 0 |
| 10/2019 | Icosavax | Series A | 0 |
| 6/2015 | Twist Bioscience | Series C | 37M |
| 1/2010 | SBA Materials | Venture Round | 5.2M |
| 3/2008 | Xtellus | Venture Round | 8.3M |
| 4/2021 | Icosavax | Series B | 0 |
| 7/2020 | Natron Energy | Series D | 0 |
| 5/2020 | SQZ Biotech | Series D | 0 |
| 12/2019 | Arctos Medical | Seed Round | 0 |
| 10/2019 | Icosavax | Series A | 0 |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 4/2019 | Inscripta | Series C | 0 |
| 12/2018 | Inscripta | Series C | 0 |
| 8/2018 | SQZ Biotech | Series C | 0 |
| 7/2018 | Serotiny | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
